tiprankstipranks
Artelo Biosciences Inc (ARTL)
NASDAQ:ARTL
US Market

Artelo Biosciences (ARTL) Income Statement

Compare
471 Followers

Artelo Biosciences Income Statement

Last quarter (Q2 2023), Artelo Biosciences's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, Artelo Biosciences's net income was $-1.60M. See Artelo Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Sep 21Sep 20Sep 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 10.29M$ 7.44M$ 4.69M$ 3.21M
Depreciation and Amortization
$ 2.00K$ -2.00K$ 500.00$ 510.00
EBITDA
$ -10.29M$ -7.44M$ -4.71M$ -4.22M
Operating Income
$ -10.29M$ -7.44M$ -4.69M$ -3.21M
Other Income/Expenses
$ 204.00K$ 2.00K$ 30.91K$ 1.04M
Pretax Income
$ -10.08M$ -7.44M$ -4.65M$ -2.17M
Net Income
$ -9.87M$ -7.44M$ -4.65M$ -2.17M
Per Share Metrics
$ ―$ ―$ ―$ ―
Basic EPS
$ -3.49$ -5.97$ -18.83$ -15.00
Diluted EPS
$ -3.49$ -5.97$ -18.83$ -15.00
Weighted Average Shares Outstanding
2.83M 1.25M 247.00K 144.00K
Weighted Average Shares Outstanding (Diluted)
2.83M 1.25M 247.18K 144.83K
Currency in USD

Artelo Biosciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis